Phathom Pharmaceuticals, Inc.

Hello, and welcome to the Fathom Pharmaceuticals first quarter 2026 earnings result call. At this time, all participants are in a listen-only mode. After the presentation, there will be a question and answer session. To ask a question during the Q&A session, you will need to press star 1-1 on your telephone keypad. Please be advised that today's call is being recorded. With that, I would like to turn the call over to Eric Chiarelli, Fathom's head of investor relations. Please go ahead.

Thank you, operator. Hello, everyone, and thank you for joining us this morning to discuss Fathom's first quarter 2026 results. This morning's presentation will include remarks from Steve Basta, our president and CEO, and Sanjeev Narula, our chief financial and business officer. A couple of notes before we get started. Earlier this morning, we issued a press release detailing the results we will be discussing during the call. A copy of that press release can be found under the news releases section of our corporate website. The recording of today's webcast and the slides we'll be reviewing can also be found on our corporate website under the events and presentations section. Before we begin, let me remind you that we will be making a number of forward-looking statements throughout today's presentation. These forward-looking statements involve risks and uncertainties, many of which are beyond Fathom's control. Actual results may materially differ from the forward-looking statements, and any such risks may materially adversely affect our business and results of operations and the trading prices for Fathom's common stock. A discussion of these statements and risk factors is available on the current Safe Harbor slide, as well as in the risk factors section of our most recent Form 10-K and subsequent SEC filings. All forward-looking statements made on this call are based on the beliefs of Fathom as of this date, and Fathom disclaims any obligation to update these statements. Later in the call, we will be commenting on both GAAP and non-GAAP financial measures. Specifically, in the scope of this discussion, when we refer to cash operating expenses, Please note we are referring to the non-GAAP form of this measure, which excludes non-cash stock-based compensation. As always, detailed reconciliations between our non-GAAP results and the most directly comparable GAAP measures are included in this morning's press release. With that, I will now turn the call over to Steve Basta, BASA's President and CEO, to kick us off.

Steve?